BioMarin to Present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4 at 6:50 AM PT / 9:50 AM ET in Boston, MA

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its upcoming participation at the TD Cowen 45th Annual Healthcare Conference in Boston, MA.

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) has announced its upcoming participation at the TD Cowen 45th Annual Healthcare Conference in Boston, MA. The company's management will deliver a presentation on Tuesday, March 4, 2025, at 6:50 AM PT / 9:50 AM ET.

The presentation will be accessible through a live audio webcast via the company's investor relations website at investors.biomarin.com. For those unable to attend live, an archived version of the presentation will be made available on BioMarin's website for a time after the conference.

Argus Session date unavailable

+3.14% session move Open Argus

Details

News Market Reaction – BMRN

The recorded move for BMRN in the trading session of this news was +3.14%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SAN RAFAEL, Calif., Feb. 25, 2025 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at the TD Cowen 45th Annual Healthcare Conference on Tuesday, March 4, 2025, at 6:50 AM PT / 9:50 AM ET in Boston, MA.

An audio webcast of the presentation will be available live. You can access the webcast at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. 

About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com. 

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-present-at-the-td-cowen-45th-annual-healthcare-conference-on-tuesday-march-4-at-650-am-pt--950-am-et-in-boston-ma-302383918.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is BioMarin (BMRN) presenting at the TD Cowen Healthcare Conference 2025?

BioMarin will present on Tuesday, March 4, 2025, at 6:50 AM PT / 9:50 AM ET in Boston, MA.

How can investors access BioMarin's (BMRN) TD Cowen conference presentation?

Investors can access the live audio webcast through BioMarin's investor relations website at investors.biomarin.com.

Will BioMarin's (BMRN) TD Cowen conference presentation be available after the event?

Yes, an archived version of the presentation will be available on BioMarin's website for a time following the conference.

Where is the TD Cowen Healthcare Conference featuring BioMarin (BMRN) being held?

The conference is being held in Boston, Massachusetts.